Strides Pharma Science Ltd
NSE:STAR
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Strides Pharma Science Ltd
NSE:STAR
|
IN |
|
N
|
NP3 Fastigheter AB
F:N33
|
SE |
|
P
|
Pioneer Motor PCL
SET:PIMO
|
TH |
|
S
|
Shimojima Co Ltd
TSE:7482
|
JP |
|
Japan Exchange Group Inc
TSE:8697
|
JP |
Intrinsic Value
Is STAR undervalued or overvalued?
See the intrinsic value estimate for Strides Pharma Science Ltd and find out whether today’s valuation is cheap or expensive by its own historical standards.
Do our valuations actually work? See backtest results .
STAR looks overvalued.
But is it expensive by its own standards?
See how today’s valuation compares with STAR’s past valuations and how the stock performed after similar periods.
Fundamental Analysis
What Strides Pharma Science Does
Strides Pharma Science makes and sells finished medicines, mainly generic and specialty drugs. Its product mix includes tablets, capsules, and sterile and non-sterile formulations used in everyday treatment areas such as infections, pain, and chronic care. The company works across development, manufacturing, and product registration, so it can take a medicine from formulation to market approval and supply it to customers.
- Headquarters
- India IN
- Employees
- 3 301
- IPO date
- Feb 3, 2000
Strides Pharma Science has no economic moat
Strides Pharma Science Ltd lacks an economic moat, leaving it vulnerable to competitive pressures and market challenges.
Read the full moat analysis
Revenue & Expenses Breakdown
Strides Pharma Science Ltd
Earnings Waterfall
Strides Pharma Science Ltd
The intrinsic value for Strides Pharma Science Ltd (STAR) under the Base Case is hidden INR.
Compared with the current market price of 1 014.8 INR, the stock appears hidden.